Natco Pharma Ltd
company logo

Natco Pharma Ltd

Pharmaceuticals
Large Cap

-

- (0%)


Natco Pharma Ltd Performance

-

-

-

-


-

-

-

-

-

Natco Pharma Ltd Fundamentals

22,944.87Cr

16.53

3.92

0.06

77.51

0.74%

326.79

i buttonClick here to know more about Fundamentals

Natco Pharma Ltd Financials

Natco Pharma Ltd Financialsright-arrow

Natco Pharma Ltd Shareholding Pattern

Natco Pharma Ltd Delivery and Volume

About Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and comp

V C Nannapaneni

1981

NATCOPHARM

NameDesignation
V C NannapaneniManaging Director
G S MurthyChairman & Independent Directo
Rajeev NannapaneniDirector & Chief Executive Off
T V RaoNon-Exec. & Independent Dir.
D G PrasadNon-Exec. & Independent Dir.
Leelaa DigumartiNon-Exec. & Independent Dir.
PSRK PrasadVice President & Director
MUR NaiduNon-Exec. & Independent Dir.
D Linga RaoPresident & Director
Pavan BhatVice President & Director
Venkat RameshCompany Sec. & Compli. Officer
A D Murthy ChavaliIndependent Director
News and Events...

Similar Stocks

What's Trending

Natco Pharma Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Natco Pharma Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Natco Pharma Ltd's share price is ₹1281.45 as of 2024-07-16.
Natco Pharma Ltd's P/E ratio is 16.53 times as of 2024-07-16.
Natco Pharma Ltd's most recent financial reports indicate a price-to-book ratio of 3.92, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Natco Pharma Ltd's market capitalization is ₹22944.87 Cr as on 2024-07-16.
The current financial records of Natco Pharma Ltd show a 14.33% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Natco Pharma Ltd's most recent financial filings, the company has a total asset value of ₹2533.7, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Natco Pharma Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Natco Pharma Ltd's 52-week high and low as of 2024-07-16 are ₹1305 and ₹1208.4, respectively.